NCT00017407View on ClinicalTrials.gov

Carboplatin and Paclitaxel With or Without ISIS 3521 in Treating Patients With Non-Small Cell Lung Cancer

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

October 13, 2000

Primary Completion Date

September 9, 2002

Study Completion Date

September 9, 2002

Conditions
Lung Cancer
Interventions
BIOLOGICAL

ISIS 3521

DRUG

carboplatin

DRUG

paclitaxel

Trial Locations (2)

92008

ISIS Pharmaceuticals, Inc., Carlsbad

44106-5065

Ireland Cancer Center, Cleveland

Sponsors
All Listed Sponsors
lead

Ionis Pharmaceuticals, Inc.

INDUSTRY